Molecules/TILDRAKIZUMAB

TILDRAKIZUMAB

Molecular Identity

AntibodyApprovedFirst approved 2018

Mechanism of action: Interleukin-23 inhibitor

Molecular Formula

0.00

Molecular Weight

g/mol

ILUMETRIIlumyaMK-3222SCH-900222TILDRAKIZUMABTILDRAKIZUMAB ASMNTILDRAKIZUMAB-ASMN

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Trials and conditions connected to TILDRAKIZUMAB

Loading drug network...